Statements 2018-01-17T21:33:19+00:00

Statements of some of our cooperation partners from joint R&D projects

“We partnered with Pharmacelsus in a joint European research project. The dedication of the Pharmacelsus team together with its high quality research and their timely delivery of results contributed to the success of this excellent partnership.”

Prof. Dr. Jan Smeitink, CEO Khondrion and Chairman Board Radboud Center for Mitochondrial Medicine, Nijmegen, the Netherlands

“It is now 10 years that we successfully cooperate with Pharmacelsus in joint R&D projects. Pharmacelsus is a reliable consortium member. What we appreciate most is the high flexibility of Pharmacelsus to cope with various issues in research.”

Dr. Katrin Zeilinger, Head of Bioreactor Group at BCRT, Charité – Universitätsmedizin Berlin, Germany

“iBET has had the good fortune of working with Pharmacelsus in a couple of complex research projects as well as in a few smaller tasks. Pharmacelsus puts together a professionally strong and broad analytical competence in their services and a very creative and forward-looking attitude to set up new, difficult to master methodologies typical of a research culture.

Thus, we consider Pharmacelsus as a partner of choice for complex needs in the biopharmaceutical areas.”

Dr. Paula M. Alves, CEO of IBET, Oeiras, Portugal

Pharmacelsus GmbH
Science Park 2
66123 Saarbruecken / Germany

Phone: +49 (0)681 3946 7510